November 18, 2026
Health news, explained with evidence
LIVE
Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine

Study Links Oral Contraceptive Use to Increased Thrombosis Risk in Japan

🏥 Public Health 2 min read 👁 3

A new study analyzing Japanese health data suggests that oral contraceptive users face a higher risk of developing thrombosis compared to non-users, with risks potentially varying by estrogen dosage and progestin type.

🏥Public Health

Key points

  • Study found a 2.1 rate ratio of thrombosis in OCP users compared to non-users.
  • Higher estrogen doses were associated with a greater risk of thrombotic events.
  • Data suggests potential differences in risk based on the type of progestin used.

Researchers from Nara Medical University and other institutions have identified a potential link between the use of oral contraceptive pills (OCPs) and an increased risk of thrombosis among women in Japan. By emulating a target trial using administrative claims data from 2014 to 2023, the study compared OCP users against a control group of non-users over a one-year follow-up period. The findings indicated that OCP users were more than twice as likely to experience a thrombotic event, with a rate ratio of 2.1.

The investigation highlights a dose-dependent relationship between the amount of ethinyl estradiol in the pills and the incidence of thrombosis. Pills containing 50 μg of ethinyl estradiol showed a higher rate ratio of 2.4, compared to 1.8 for those with lower dosages. Furthermore, the researchers observed that within an extended three-year analysis, pills containing drospirenone appeared to carry a higher risk compared to those containing norethisterone.

What to know: While these findings suggest a correlation, the study is based on administrative claims data, which may have limitations compared to randomized clinical trials. Thrombosis risk is a known factor in hormonal contraceptive use, and individuals should consult with their healthcare provider to discuss the specific risks and benefits based on their personal medical history.

Source Nature Health Sciences — nature.com/articles/s41598-026-74972-9 ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.